knowledge -WSS

knowledge

author：Wikipedia 2025-09-06 01:50:45 - browse：8162

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

focus

WSS

The world needs the new pandemic treaty

New research sheds light on how often breast cancer is overdiagnosed

Decentralized clinical trials need collaboration to achieve wider use

Ripples from Flovent's discontinuation is killing children with asthma

Supreme Court to hear if Covid misinformation is protected speech

Stroke rates rising, especially in working

hotspot

knowledge

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

What a koala virus tells us about the human genome

Drug repurposing or repositioning? The language matters

Beyond aggravation: Constipation is an American epidemic

New air purifier tech could be key to improving indoor air quality

Asahi Kasei to buy Calliditas, picking up kidney disease drug

At least 13 dead in Texas as scorching temps continue

Why some fertility treatments produce more boy babies

Continuity nursing helped my family in our darkest PICU moments

Hottest summer in 2,000 years puts focus on extreme heat, health

Wikipedia

CVS is willing to dump 10% of its Medicare Advantage members

Abbott's new stent may help patients with peripheral artery disease

Lilly’s weekly insulin works as well as daily products, new studies show

HHS suspends federal funding for EcoHealth Alliance

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

hotspot

hotspot

focus

explore